Clinical Trials Browser

INDUSTRY × Lymphoma, Follicular × ofatumumab × Clear all

NCT01077518 2020-03-27

A+B

Phase 3 Terminated

346 enrolled 41 charts

Lymphoma, Follicular, Neoplasms

NCT00742144 2017-11-17

Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia

Phase 1 Completed

LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00092274 2015-04-21

Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma

Phase 1/2 Withdrawn

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT00494780 2014-07-11

MUNIN

Phase 2 Completed

59 enrolled 21 charts

Lymphoma, Follicular

NCT00394836 2014-01-29

HuMax-CD20 i(Ofatumumab) n Follicular Lymphoma (FL) Patients Refractory to Rituximab

Phase 2 Completed

116 enrolled 22 charts

Lymphoma, Follicular